Losartan drug interactions
Pro Research Analysisby 
Searched over 200M research papers
Losartan Drug Interactions: Key Insights
Major Drug Interactions with Losartan
Losartan, a commonly prescribed antihypertensive, is known to interact with several other medications. Notably, it has major interactions with other antihypertensive agents such as captopril, enalapril, and lisinopril, as well as with lithium. These combinations can increase the risk of adverse effects or reduce therapeutic efficacy, so they should generally be avoided or closely monitored.
Moderate and Notable Interactions
Moderate interactions have been reported between losartan and drugs like aspirin, pregabalin, alprazolam, amitriptyline, baclofen, betamethasone, and buspirone. These interactions may not always require avoidance but do necessitate careful monitoring for side effects or reduced effectiveness.
Interactions with Antiepileptic and Antiemetic Drugs
Co-administration of losartan with carbamazepine has been shown to reduce the effectiveness of losartan, likely due to increased clearance and reduced plasma concentration, leading to therapeutic failure. Therefore, this combination should be avoided. Similarly, when losartan is taken with aprepitant, both drugs significantly alter each other's pharmacokinetics, suggesting the need for caution and further investigation before using them together.
Interactions with Herbal and Dietary Compounds
Herbal supplements and dietary components can also affect losartan's action. Curcuma longa (turmeric) and Lepidium sativum (garden cress) both increase the plasma concentration and blood pressure-lowering effect of losartan, which may require dose adjustments and close blood pressure monitoring. Quercetin, a compound found in many herbs and foods, increases losartan's bioavailability, potentially raising the risk of side effects or toxicity. Patients on losartan should be cautious with herbal preparations containing quercetin.
Cytochrome P450 Enzyme Interactions
Losartan is metabolized primarily by the cytochrome P450 enzymes CYP2C9 and CYP3A4. Drugs that induce or inhibit these enzymes can alter losartan's effectiveness. For example, combining losartan with phenobarbital, rifampin, or fluconazole requires careful therapeutic drug monitoring due to potential changes in drug levels. Additionally, losartan and phenytoin, both CYP2C9 substrates, may interact and increase the risk of concentration-related adverse effects.
Interactions with Antidepressants
Losartan can interact with certain selective serotonin reuptake inhibitors (SSRIs), especially fluoxetine and sertraline, when used in combination with other drugs like gefitinib. These combinations can significantly alter the metabolism of losartan and the other drugs involved, highlighting the importance of monitoring and possibly adjusting dosages in multidrug regimens.
Conclusion
Losartan is involved in a range of drug interactions, from major to moderate, with both prescription medications and herbal supplements. The most significant interactions involve other antihypertensives, antiepileptics, certain antidepressants, and herbal compounds that affect cytochrome P450 enzymes. Patients and healthcare providers should be vigilant about potential interactions, especially in cases of polypharmacy or when introducing new medications or supplements. Regular monitoring and possible dose adjustments are essential to ensure safety and therapeutic effectiveness.
Sources and full results
Most relevant research papers on this topic